Cancer Prevention with Molecular Target Therapies 3.0
Personalized medicine is playing an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. This Special Issue brings together original research and review articles on molecular on...
Saved in:
Other Authors: | |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000naaaa2200000uu 4500 | ||
---|---|---|---|
001 | doab_20_500_12854_101337 | ||
005 | 20230714 | ||
003 | oapen | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 20230714s2023 xx |||||o ||| 0|eng d | ||
020 | |a books978-3-0365-7908-5 | ||
020 | |a 9783036579092 | ||
020 | |a 9783036579085 | ||
040 | |a oapen |c oapen | ||
024 | 7 | |a 10.3390/books978-3-0365-7908-5 |c doi | |
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a GP |2 bicssc | |
072 | 7 | |a PS |2 bicssc | |
100 | 1 | |a Paleari, Laura |4 edt | |
700 | 1 | |a Paleari, Laura |4 oth | |
245 | 1 | 0 | |a Cancer Prevention with Molecular Target Therapies 3.0 |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 electronic resource (318 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
520 | |a Personalized medicine is playing an important role in cancer prevention. To date, it is clear that many cancers are molecularly distinct subtypes, and different therapeutic approaches would be required for each. This Special Issue brings together original research and review articles on molecular oncology with attention to the early detection and prevention of cancer. It highlights new findings, methods, and technical advances in molecular cancer research. The main feature of this reprint was to provide an open-source sharing of significant works in the field of molecular oncology that can increase our understanding of cancer development. Topics include:Molecular methods to personalize cancer screening and detection;Molecular target therapies to prevent cancer development and metastases;Identification and new aspects of cellular signaling molecules and pathways for target discovery, drug design and personalized and gender medicine;Drug repurposing for cancer prevention;Molecular modeling studies. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Research & information: general |2 bicssc | |
650 | 7 | |a Biology, life sciences |2 bicssc | |
653 | |a colorectal cancer | ||
653 | |a adenomas | ||
653 | |a array comparative genomic hybridization | ||
653 | |a long non-coding RNA | ||
653 | |a MALAT1 | ||
653 | |a COVID-19 | ||
653 | |a SARS-CoV-2 | ||
653 | |a ketogenic diet | ||
653 | |a nutrition in pregnancy | ||
653 | |a microbiota | ||
653 | |a cancer | ||
653 | |a carcinoma | ||
653 | |a precision medicine | ||
653 | |a health promotion | ||
653 | |a metabolomics | ||
653 | |a amino acid restriction | ||
653 | |a glucose restriction | ||
653 | |a mass spectrometry | ||
653 | |a low carb | ||
653 | |a 2-deoxy-D-glucose | ||
653 | |a 2-DG | ||
653 | |a methionine | ||
653 | |a perfusion culture | ||
653 | |a energy restriction | ||
653 | |a caloric restriction | ||
653 | |a target discovery | ||
653 | |a epithelial-mesenchymal transition (EMT) | ||
653 | |a RNA-binding protein 3 (RBMS3) | ||
653 | |a carcinogenesis | ||
653 | |a target therapy | ||
653 | |a zinc fingers | ||
653 | |a homeoboxes | ||
653 | |a ZHX1 | ||
653 | |a ZHX2 | ||
653 | |a ZHX3 | ||
653 | |a HCC | ||
653 | |a miR-221 | ||
653 | |a astrocyte elevated gene-1 | ||
653 | |a angiogenesis | ||
653 | |a cell proliferation | ||
653 | |a regulatory genes | ||
653 | |a α-catulin | ||
653 | |a CTNNAL1 | ||
653 | |a catenin | ||
653 | |a invasion | ||
653 | |a epithelial-mesenchymal transition | ||
653 | |a EMT | ||
653 | |a vascular mimicry | ||
653 | |a statins | ||
653 | |a repurposed drugs | ||
653 | |a gynecological cancer | ||
653 | |a endometrial cancer | ||
653 | |a ovarian cancer | ||
653 | |a cervical cancer | ||
653 | |a NSCLC | ||
653 | |a BPR0C261 | ||
653 | |a radiosensitivity | ||
653 | |a DNA damage | ||
653 | |a microtubule inhibitor | ||
653 | |a p53 | ||
653 | |a PTEN | ||
653 | |a acridine-triazole | ||
653 | |a acridine-thiadiazole | ||
653 | |a topoisomerase I | ||
653 | |a anti-angiogenesis | ||
653 | |a zebrafish | ||
653 | |a neuroblastoma | ||
653 | |a ATRX | ||
653 | |a MYCN | ||
653 | |a ClpPX protease | ||
653 | |a ONC201 | ||
653 | |a apoptosis | ||
653 | |a mitochondria | ||
653 | |a liquid biopsy | ||
653 | |a lung cancer | ||
653 | |a biomarkers | ||
653 | |a dysgeusia | ||
653 | |a dysosmia | ||
653 | |a taste | ||
653 | |a smell | ||
653 | |a cancer treatment | ||
653 | |a rapid review | ||
653 | |a glycolysis | ||
653 | |a cancer metabolism | ||
653 | |a combination therapy | ||
653 | |a Akt | ||
653 | |a anti-inflammatory action | ||
653 | |a COX-1 | ||
653 | |a hydrazones | ||
653 | |a non-small cell lung cancer | ||
653 | |a thiosemicarbazides | ||
653 | |a gastric cancer | ||
653 | |a pepsinogen | ||
653 | |a gastrin G17 | ||
653 | |a Helicobacter pylori | ||
653 | |a screening | ||
856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/7432 |7 0 |z DOAB: download the publication |
856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/101337 |7 0 |z DOAB: description of the publication |